Trial intelligence / Profile preview

VASUS: TachoSil vs Surgicel Original in Vascular Surgery

NCT01500135Phase 3Completed

Sponsor
Takeda
Start
Mar 2012
Primary completion
Jun 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of tachosil in Not applicable, sponsored by Takeda. Started Mar 2012; status: completed.

02

Drugs

tachosil
03

Conditions

Not applicable

Beyond the preview

Go deeper on NCT01500135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01500135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call